All Pathways
Pulmonary MedicineManagement

High-Flow Nasal Cannula (HFNC) Therapy

High-Flow Nasal Cannula (HFNC) Therapy: Acute Hypoxemic Respiratory Failure → HFNC Indicated? → ⚠️ Consider NIV/Intubation Instead → Intubation.

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Acute Hypoxemic Respiratory Failure

    Hypoxia despite conventional O2 therapy

    1. Decision

      HFNC Indicated?

      Assess suitability

      • INDICATIONS:
      • • Hypoxemia despite O2 15L/min NRB
      • • Type 1 respiratory failure
      • • Post-extubation support
      • • Immunocompromised with ARF
      • • Pre-oxygenation for intubation
      • • Palliative comfort
      1. Warning

        ⚠️ Consider NIV/Intubation Instead

        HFNC may not be appropriate

        • Hypercapnic respiratory failure (Type 2)
        • Severe acidosis (pH <7.25)
        • Hemodynamic instability
        • Decreased consciousness (GCS <12)
        • Unable to protect airway
        • Facial trauma/surgery
        1. Outcome

          Intubation

          HFNC failure

          • Do not delay intubation if failing
          • HFNC can be used during apneic oxygenation
          • Experienced intubator preferred
          • Video laryngoscopy recommended
      2. Action

        Initiate HFNC

        Starting settings

        • Flow: Start at 30-40 L/min
        • FiO2: Start at 0.6-1.0 (titrate to SpO2)
        • Temperature: 37°C (or 34°C if not tolerated)
        • Nasal prongs sized appropriately
        • Ensure proper humidification
        1. Action

          Titrate Settings

          Optimize flow and FiO2

          • FLOW: Increase to 50-60 L/min if needed
          • Higher flow = more PEEP effect, CO2 washout
          • FiO2: Titrate to SpO2 92-96% (88-92% if COPD)
          • Reduce flow if discomfort/nasal dryness
          1. Action

            Close Monitoring

            Assess response hourly

            • Respiratory rate (target <25-30/min)
            • SpO2 on current settings
            • Work of breathing
            • Patient comfort
            • ROX index at 2, 6, 12 hours
            1. Decision

              Calculate ROX Index

              Predict HFNC success/failure

              • ROX = (SpO2/FiO2) / Respiratory Rate
              • At 2h: ROX ≥4.88 = likely success
              • At 6h: ROX ≥4.88 = likely success
              • At 12h: ROX <3.85 = likely failure
              • Lower ROX = higher intubation risk
              1. Action

                ROX ≥4.88 (Favorable)

                Continue HFNC

                • Low intubation risk
                • Continue current settings
                • Wean FiO2 if SpO2 above target
                • Can consider flow reduction later
                1. Action

                  Weaning HFNC

                  When improving

                  • Reduce FiO2 first (to 0.4 or less)
                  • Then reduce flow (by 5-10 L/min steps)
                  • Monitor for rebound hypoxemia
                  • Consider trial on nasal cannula
                  1. Outcome

                    Transition to Conventional O2

                    Weaning successful

                    • If SpO2 maintained on low-flow HFNC
                    • Trial simple nasal cannula or mask
                    • Monitor closely after transition
                    • Can return to HFNC if needed
              2. Action

                ROX 3.85-4.88 (Intermediate)

                Heightened vigilance

                • Increase monitoring frequency
                • Optimize settings
                • Prepare for escalation if declining
                • Repeat ROX in 2 hours
                1. Decision

                  Clinical Deterioration?

                  Signs of HFNC failure

                  • Worsening hypoxemia despite max settings
                  • RR increasing >35-40/min
                  • Accessory muscle use worsening
                  • Hemodynamic instability
                  • Altered mental status
              3. Warning

                ⚠️ ROX <3.85 (Unfavorable)

                High failure risk

                • Consider early intubation
                • Do not delay if deteriorating
                • Trial of NIV may be considered
                • Avoid prolonged HFNC failure

Guideline Source

High-Flow Nasal Cannula Oxygen Therapy: Evidence and Practice

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Settings require individual titration
  • Not a substitute for invasive ventilation in severe cases
  • Patient tolerance varies
  • Humidification settings depend on device

Applicable Regions

Global

Global: Device availability and protocols vary by institution

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the High-Flow Nasal Cannula (HFNC) Therapy?

The High-Flow Nasal Cannula (HFNC) Therapy is a management clinical algorithm for Pulmonary Medicine. It provides a structured decision tree to guide clinical decision-making, based on High-Flow Nasal Cannula Oxygen Therapy: Evidence and Practice.

What guideline is the High-Flow Nasal Cannula (HFNC) Therapy based on?

This algorithm is based on High-Flow Nasal Cannula Oxygen Therapy: Evidence and Practice (DOI: 10.1164/rccm.202205-0901OC).

What are the limitations of the High-Flow Nasal Cannula (HFNC) Therapy?

Known limitations include: Settings require individual titration; Not a substitute for invasive ventilation in severe cases; Patient tolerance varies; Humidification settings depend on device. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the High-Flow Nasal Cannula (HFNC) Therapy appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free